首页> 美国卫生研究院文献>American Journal of Human Genetics >Absence of cross-reacting material in isolated propionyl CoA carboxylase deficiency: nature of residual carboxylating activity.
【2h】

Absence of cross-reacting material in isolated propionyl CoA carboxylase deficiency: nature of residual carboxylating activity.

机译:分离的丙酰辅酶A羧化酶缺乏症中缺乏交叉反应物质:残余羧化活性的性质。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fibroblast extracts and fetal liver homogenates from patients with propionic acidemia due to inherited deficiency of propionyl CoA carboxylase (PCC) were analyzed for the presence of immunologically cross-reactive PCC protein. Using several rabbit antisera raised against homogeneous human liver PCC, homogeneous pig heart PCC, or the individual non-identical subunits of the human liver enzyme, we found no detectable cross-reacting material by direct or competitive immunotitration in several cell lines from patients in either major complementation group (pcc A; pcc C) with isolated PCC deficiency. In contrast, cells of a patient from the bio complementation group contained normal amounts of immunoreactive PCC. Further analysis of the pcc A and pcc C mutants revealed that their residual propionyl CoA carboxylating activity varied greatly depending on the concentration of extract or homogenate protein used in the PCC assay. When propionyl CoA carboxylation was assayed at high protein concentration in a fetal liver homogenate from a pcc C patient, the apparent PCC activity was comparable to that found in normal human fetal liver. Significantly, the specific activity in the mutant, but not in the control, extract declined steeply as protein concentration was lowered, and this loss could not be prevented by adding PCC substrates, bovine serum albumin, glycerol, or 2-mercaptoethanol. Moreover, detailed analyses of immunotitration curves of control fibroblasts extracts showed that fresh extracts contained an amount of nonimmunotitratable carboxylating activity corresponding to the residual activity present in fresh extracts of mutant cell lines. We conclude that the residual propionyl CoA carboxylating activity found in isolated PCC deficiency represents another carboxylase that can utilize propionyl CoA as a substrate rather than a mutant form of PCC with markedly different immunochemical and physicochemical properties.
机译:分析了丙酸CoA羧化酶(PCC)遗传性遗传缺陷引起丙酸血症患者的成纤维细胞提取物和胎儿肝匀浆的免疫交叉反应性PCC蛋白的存在。使用几种针对均质人肝PCC,均质猪心PCC或人肝酶的个别不同亚基的兔抗血清,我们发现在两种细胞中,患者的几种细胞系均无法通过直接或竞争性免疫滴定检测到可检测到的交叉反应物质主要互补组(pcc A; pcc C),患有孤立的PCC缺乏症。相反,来自生物互补组的患者细胞含有正常量的免疫反应性PCC。对pcc A和pcc C突变体的进一步分析表明,它们残留的丙酰CoA羧化活性取决于PCC分析中提取物或匀浆蛋白的浓度而有很大差异。当在来自pcc C患者的胎儿肝匀浆中以高蛋白浓度测定丙酰CoA羧化时,表观PCC活性与正常人胎儿肝中的PCC活性相当。值得注意的是,随着蛋白质浓度的降低,突变体(而非对照)提取物中的比活性急剧下降,并且无法通过添加PCC底物,牛血清白蛋白,甘油或2-巯基乙醇来防止这种损失。而且,对对照成纤维细胞提取物的免疫滴定曲线的详细分析表明,新鲜提取物含有一定量的不可免疫处理的羧化活性,其对应于突变细胞系新鲜提取物中存在的残留活性。我们得出的结论是,在孤立的PCC缺陷中发现的残留的丙酰CoA羧化活性代表了另一种羧化酶,可以利用丙酰CoA作为底物,而不是具有明显不同的免疫化学和物理化学特性的PCC突变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号